Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Inventory (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Change in Inventory for 13 consecutive years, with -$7.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 1171.26% year-over-year to -$7.6 million, compared with a TTM value of -$24.8 million through Dec 2025, down 327.13%, and an annual FY2025 reading of -$24.8 million, down 327.13% over the prior year.
  • Change in Inventory was -$7.6 million for Q4 2025 at Tandem Diabetes Care, down from -$5.2 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $19.9 million in Q1 2023 and bottomed at -$10.4 million in Q3 2024.
  • Average Change in Inventory over 5 years is $3.1 million, with a median of $1.5 million recorded in 2021.
  • The sharpest move saw Change in Inventory skyrocketed 7149.58% in 2022, then crashed 1171.26% in 2025.
  • Year by year, Change in Inventory stood at $3.0 million in 2021, then soared by 78.24% to $5.4 million in 2022, then skyrocketed by 147.48% to $13.3 million in 2023, then tumbled by 104.46% to -$595000.0 in 2024, then plummeted by 1171.26% to -$7.6 million in 2025.
  • Business Quant data shows Change in Inventory for TNDM at -$7.6 million in Q4 2025, -$5.2 million in Q3 2025, and -$2.5 million in Q2 2025.